Isotechnika Pharma Inc IPHAF

Well Funded US Biotechs........weepee

[stockman6]

weepee wrote: ""You must have selectively only looked at Canadian biotechs."" wouldn't this make sense, as ISA is a Canadian biotech? You implied ISA was "different" in it's valuation, so I looked at it in relation to its peers. And you were wrong. Nevertheless, see below...... ""Look at the field of well funded biotechs in the US and you will see that many of them are at or below cash value. All "hot air" balloons like ISA must eventually come back down to earth."" OK weepee, I checked out "well funded US biotechs". Specifically, 234 stocks, on the US biotech Index. What do you think I found?? Average Market Cap: $779 Million Average Cash: $147 Million Median Market Cap: $113 Million Median Cash: $54 Million AVERAGE: 5.3x cash MEDIAN: 2.1x cash As this list contains all types of biotechs, inluding geonomics, etc., I though I'd narrow it down a bit, only looking at those companies working in the Autoimmune area. The results?? AVERAGE: 2.2x cash MEDIAN: 3.33x cash So, where should I look next. Maybe Venezuela, the target group for ASTR?? Or India??